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Summary
The antibiotic compound pyrroindomycin B contains
an indole ring chlorinated in the 5 position. The indole
ring is probably derived from tryptophan, and thus
primers derived from conserved regions of trypto-
phan halogenases were used to amplify and clone a
DNA fragment that was then used to isolate a trypto-
phan 5-halogenase gene (pyrH) from a cosmid library
of the pyrroindomycin producer Streptomyces ru-
gosporus LL-42D005. A gene disruption mutant in the
tryptophan 5-halogenase gene no longer produced
pyrroindomycin B, but still produced pyrroindomycin
A, the nonhalogenated derivative. The halogenase
gene could be overexpressed in Pseudomonas fluo-
rescens BL915 ORF1 and was purified to homo-
geneity by immobilized metal chelate ion affinity
chromatography. Chlorinating and brominating activi-
ties with tryptophan as a substrate were detected in
cell-free extracts and for the purified enzyme.
Introduction
The pyrroindomycins A and B (Figure 1) were isolated
by Ding et al. in 1994 [1]. Pyrroindomycin A and B ex-
hibit good to excellent in vitro activity against gram-
positive bacteria such as methicillin-resistant Staphy-
lococcus aureus strains and poor activity against
gram-negative bacteria, with pyrroindomycin A show-
ing a higher antibacterial activity than the chlorinated
derivative pyrroindomycin B [2]. The pyrroindomycins
are composed of a pyrroloindole entity linked via an
ester bond to an unbranched deoxytrisaccharide. A
polyketide macro-ring system containing a tetramic*Correspondence: karl-heinz.vanpee@chemie.tu-dresden.de
4 Present address: Theodor-Boveri-Institut für Biowissenschaften
(Biozentrum) der Universität Würzburg, Am Hubland, 97074
Würzburg, Germany.acid functionality is connected to the other end of the
trisaccharide through a glycosidic linkage. Whereas
pyrroindomycin B contains a chlorine atom, pyrroindo-
mycin A is the nonhalogenated derivative. Tryptophan
is presumed to be the precursor for the pyrroloindole
moiety [3]. The first step in the biosynthesis of the anti-
fungal antibiotic pyrrolnitrin is the regioselective chlori-
nation of tryptophan in the 7 position [4]. This is also
assumed for the antitumor compound rebeccamycin
[5]. Genes coding for enzymes catalyzing the regiose-
lective chlorination of tryptophan in the 7 position have
been isolated from several pyrrolnitrin-producing bac-
teria [6, 7]. Purification and characterization of the cor-
responding enzyme showed that it belongs to a novel
type of halogenating enzymes. These halogenases are
part of a two component system consisting of a flavin
reductase and the actual halogenase. The flavin reduc-
tase is required for the formation of FADH2 from FAD
and NADH [8]. From the rebeccamycin producer Leche-
valieria aerocolonigenes, a gene with high similarity to
the tryptophan 7-halogenase gene from the pyrrolnitrin
biosynthetic gene cluster was isolated [5], supporting
the assumption that in rebeccamycin biosynthesis tryp-
tophan is also halogenated in the 7 position. If the pre-
sumption that in the biosynthesis of pyrroindomycin B
chlorination of tryptophan should take place was cor-
rect, it should be possible to detect the gene of this
tryptophan 5-halogenase by PCR using primers derived
from conserved regions of the tryptophan 7-halo-
genase genes isolated so far. The alignment of the
amino acid sequences of the tryptophan 7-halo-
genases involved in pyrrolnitrin biosynthesis and the
putative tryptophan 7-halogenase from the rebecca-
mycin producer showed the presence of a few con-
served regions suitable for the constructions of PCR
primers. Here we report the cloning and expression of
a tryptophan 5-halogenase gene, the purification of the
enzyme in active form, the identification of the enzy-
matic product, and the proof for the involvement of this
tryptophan 5-halogenase in pyrroindomycin B biosyn-
thesis.
Results and Discussion
Detection of the Tryptophan 5-Halogenase Gene
Comparison of published amino acid sequences of
tryptophan 7-halogenases from pyrrolnitrin-producing
bacteria [7] and the putative tryptophan 7-halogenase
involved in rebeccamycin biosynthesis in Lechevalieria
aerocolonigenes [5] allowed the identification of four
conserved regions (Figure 2) suitable for the construc-
tion of four PCR primers. Using these primers in four
combinations with total DNA from the pyrroindomycin
producer Streptomyces rugosporus as the template
DNA, a fragment of w700 bp (PCR-hal) could be ampli-
fied with a combination of primers SZ003 and SZ005.
Sequencing and analysis of the 700 bp PCR product
shows an identity at the amino acid level to the trypto-
phan halogenases used for the sequence alignment be-
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446Figure 1. Chemical Structures of Pyrroindomycins A and B
See text for details.
F
g
ttween 31% and 33%. When PCR-hal was used as the
Pprobe in colony screening of a cosmid library of S. rugo-
asporus, five positive clones were detected. Subcloning
t
of an w4300 bp BamHI fragment from the positive cos- a
mid clone 6C1 into pBluescript II SK (+) resulted in plas- b
mid pB1G. Sequencing of a DNA region of 2564 bp s
qaround the PCR-hal hybridizing region revealed the
presence of an orf of 1536 bp, named pyrH showing
the typical high GC content of Actinomyces genes [9].
nThe deduced gene product revealed similarities to sev-
peral known tryptophan halogenases. PyrH showed 56%
fsimilarity to the tryptophan 7-halogenase from Pseu-
sdomonas fluorescens whose in vitro activity has been
rdemonstrated [10] and 52% sequence similarity to
cRebH from Lechevalieria aerocolonigenes [5]. The de-
gduced amino acid sequence contains both crucial mo-
stifs of FADH2-dependent halogenases [11]. The first
vmotif (GxGxxG) is located near the N terminus of the
protein and is known to be involved in the binding of
tnucleotide cofactors and is common to a number of
2FAD- and NAD(P)H-dependent enzymes [12]. The sec-
Hond motif (GWxWxIP), also conserved in all known
FADH2-dependent halogenases, is located in the mid-
dle of the deduced gene product. PyrH was assumed
(later confirmed, see below) to be the tryptophan
5-halogenase of the pyrroindomycin biosynthetic gene
cluster (the sequence was deposited in GenBank with
accession number AY623051).
Heterologous Expression of the Tryptophan
5-Halogenase Gene pyrH, Purification of the
Enzyme, and In Vitro Halogenation of Tryptophan
In order to assay the putative tryptophan 5-halogenase
activity of PyrH, its coding gene was heterologously ex-
pressed in Pseudomonas fluorescens BL915 ORF1,
as a N-terminal His-tagged protein, using plasmid
pSZexM2. Overproduction of the protein was verified
by SDS-PAGE of cell extracts (Figure 3). The protein
was produced in soluble form. Halogenating activity
in crude extracts from P. fluorescens BL915 ORF1
pSZexM2 was investigated by a specific enzyme assay.
FAlthough not absolutely necessary for halogenating ac-

tivity in crude extracts, an overexpressed flavin reduc-
Ltase from Escherichia coli (Fre) [13] was added to the
(
enzyme assay to ensure the formation of enough p
FADH2 required by halogenases [8]. c
lPyrH was purified to homogeneity by immobilizedigure 2. Comparison of Tryptophan Halogenase Sequence Re-
ions Used for the Construction of PCR Primers for the Amplifica-
ion of Tryptophan Halogenase Gene Fragments
rnA-A, tryptophan 7-halogenase (trp 7-hal) from Pseudomonas
ureofaciens; PrnA-B, trp 7-hal from Burkholderia cepacia; PrnA-F,
rp 7-hal from P. fluorescens; RebH, trp 7-hal from Lechevalieria
erocolonigenes; PrnA-M, trp 7-hal from Myxococcus fulvus. Black
oxes show conserved amino acid positions, gray boxes show
imilar amino acids, and conserved motifs are shown below the se-
uences.PLC-ESI-MS (Figure 4A). The position of chlorine in-
igure 3. SDS-PAGE of Crude Extracts from P. fluorescens BL915
ORF1 pSZexM2 (pyrH) and of Purified PyrH
ane 1, crude extract from P. fluorescens BL915 ORF1 pCIBhis
25 g); lane 2, crude extract from P. fluorescens BL915 ORF1
SZexM2 (pyrH, 20 g); lane 3, run-through from the nickel chelate
hromatography column (15 g); lane 4, washing fraction (22 g);
ane 5, purified PyrH (7 g); lane 6, molecular weight standard.ickel chelate affinity chromatography (Figure 3). The
urified enzyme did not contain flavin or any other co-
actor with an absorbance in the visible range of the
pectrum. Whereas the addition of FAD and of a flavin
eductase was not necessary in the case of the crude
ell-free extract, it was absolutely necessary for halo-
enating activity of the purified enzyme. Purified PyrH
howed a turnover number of 8.13 × 10−3 s−1 and a Km
alue of 0.15 mM with L-tryptophan as the substrate.
Using purified PyrH, in the presence of chloride and
ryptophan, monochlorinated tryptophan ([M+H]+ =
38.9 amu) was obtained, as detected by HPLC and
Tryptophan 5-Halogenase
447Figure 4. UV-Chromatograms and Total Ion
Chromatograms of the Tryptophan 5-Halo-
genase Activity Assay
(A) UV- and TIC traces of the enzyme assay
in the presence of chloride and correspond-
ing mass spectra (Rt = 3.8 min) of 5-chloro-
tryptophan (Cl-Trp) ([M+H]+ = 238.9 amu;
[2M+H]+ = 477.0 amu).
(B) UV- and TIC traces of the enzyme assay
in the presence of bromide and correspond-
ing mass spectra (Rt = 3.9 min) of 5-bromo-
tryptophan (Br-Trp) ([M+H]+ = 283.0 amu;
[2M+H]+ = 566.8 amu).corporation was elucidated by 1H-NMR (D2O, 500.13
MHz). 2-H was observed at δ 7.35 (s), and 4-H at δ 7.62
(d) was found to be coupled with 6-H (dd) at δ 7.12 (J =
2.0 Hz). 6-H was also found to be coupled with 7-H at
δ 7.35 (d, J = 8.7). These data for the chemical shift and
coupling constants of the aromatic H of enzymatically
produced chlorotryptophan were identical with the data
obtained from authentic 5-chlorotryptophan. When chlo-
ride was substituted with bromide in the enzyme assay,
monobrominated tryptophan was formed as identifiedby HPLC and HPLC-ESI-MS ([M+H]+ = 283 amu) (Figure
4B). Chlorination is favored over the incorporation of
bromide. Brominating activity is only about 75% of the
chlorinating activity. At bromide concentrations <1 mM,
5-chlorotryptophan is also formed, although chloride
was not added to the enzyme assay. This is due to the
presence of chloride as an inevitable contamination in
the enzyme assay. Only a single chlorinated or bromi-
nated product could be detected, respectively, showing
that the enzyme was a halogenase catalyzing the regio-
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448Figure 5. Generation of Mutant Streptomy-
ces rugosporus SZTF1Hal
(A) Construction of plasmid pSZ614.
(B) Construction of the gene disruption mu-
tant Streptomyces rugosporus SZTF1Hal. B,
BamHI; P, PaeI.; #pyrH and pyrH# are each
incomplete copies of pyrH; aac3IV is the
apramycin resistance gene; tsr, thiostrepton
resistance gene.selective monohalogenation of tryptophan at the 5 po- I
Bsition. Crude cell-free extract prepared from a control
strain of P. fluorescens harbouring the vector plasmid T
twithout the tryptophan 5-halogenase gene, showed no
halogenating activity. anvolvement of PyrH in Pyrroindomycin
iosynthesis
o find indications for the pyrroindomycin B biosyn-
hetic gene cluster, flanking regions 3000 bp upstream
nd 1000 bp downstream of pyrH, respectively, were
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449Figure 6. Data from the HPLC-ESI-MS Characterization of the Pyrroindomycin Metabolites from Streptomyces rugosporus SZTF1Hal and the
Wild-Type Strain
(A) Mass spectra of pyrroindomycins produced by the wild-type strain. Pyrroindomycin A ([M+H]+ = 1097.6 amu/Rt = 6.6 min); pyrroindomycin
B ([M+H]+ = 1131.6 amu/Rt = 6.7 min); methylated pyrroindomycin B ([M+H]+ = 1145.5 amu/Rt = 6.7 min).
(B) Mass spectra of pyrroindomycins produced by S. rugosporus SZTF1Hal. Pyrroindomycin A ([M+H]+ = 1097.6 amu/Rt = 6.6 min); methylated
pyrroindomycin A ([M+H]+ = 1111.6 amu/Rt = 6.7 min).sequenced. Analysis of the DNA sequences for the
presence of potential coding regions revealed three po-
tential open reading frames, two upstream and one
downstream of pyrH. All of them showed a high GC
content, characteristic of Streptomyces genes and thebias in the third codon position characteristic of the
genes of this genus. The deduced amino acid se-
quences showed no significant similarities with pro-
teins involved in the biosynthesis of similar secondary
metabolites (data not shown).
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450Therefore, in order to prove the involvement of PyrH
lin the biosynthesis of pyrroindomycin B, a gene disrup-
ption mutant was constructed. For this purpose, plasmid
i
pSZ614 was generated. Plasmid pSZ614 containing the p
pyrH gene disrupted by an apramycin resistance gene w
s(Figure 5A) is a bifunctional mobilizable plasmid that is
Nunstable in S. rugosporus. This plasmid was introduced
pinto the wild-type strain S. rugosporus by conjugation
from E. coli. This experiment resulted in the apramycin-
Dresistant and thiostrepton-sensitive mutant SZTF1Hal,
P
where the mutated gene replaced the wild-type copy of k
the chromosome via homologous recombination (Fig- t
ure 5B). The recombination event was confirmed by [
aSouthern analysis of chromosomal DNA from mutant
pSZTF1Hal and its comparison to the wild-type strain.
w
m
Mass Spectrometric Characterization of the r
(Biosynthetic Products of the Mutant SZTF1Hal
STo identify the pyrroindomycins produced by mutant
rSZTF1Hal, cell extracts of this strain were analyzed by
a
HPLC-ESI-MS. The mass spectra derived from these c
investigations indicated the production of pyrroindo- d
mycin A and methylated pyrroindomycin A, but not that p
Iof pyrroindomycin B (Figure 6B). According to the char-
Eacteristic isotopic pattern, the pyrroindomycin variants
[synthesized by mutant strain SZTF1Hal did not contain
C
any chlorine atoms, as evident from the mass shifts of H
34 atomic mass units to lower masses in comparison to g
the corresponding signals from the wild-type extracts
(Figures 6A and 6B). P
D
gSignificance
f
k
Regioselectively acting halogenases are enzymes c
fthat are responsible for the biosynthesis of a large
ovariety of halogenated secondary metabolites. In
Gmany cases the biological activity of these metabo-
Slites is significantly influenced by the halogen substit-
S
uents. Isolation and characterization of the genes of S
specific halogenases and understanding the bio- m
1chemistry of these enzymes are prerequisites for ge-
Dnetic engineering aiming at the production of novel
dhalogenated compounds by combinatorial biosynthe-
psis. In the work presented here, a halogenase with
P
novel regioselectivity was isolated. To our knowl- b
edge, this enzyme is the first tryptophan 5-halo-
genase and only the second halogenase purified in C
active form, and one of only three specific halo- F
tgenases for which the enzymatic activity and the in-
tvolvement in the biosynthesis of a halogenated me-
ttabolite could be shown. The availability of this
e
specific halogenase is expected to open up novel s
possibilities for combinatorial biosynthesis and the p
enzymatic production of halogenated compounds. t
p
SExperimental Procedures
Bacterial Strains, Culture Conditions, and Vectors G
FStreptomyces rugosporus NRRL 21084 [1], Escherichia coli XL1
Blue MRA [Stratagene], E. coli JM109 (DE3) pEE1001 [14], and f
BPseudomonas fluorescens BL915 ORF1 [6] were used in this
work. For sporulation, S. rugosporus was routinely grown at 30°C t
Ton agar plates containing MS medium for 7 days [15]. Cultures ofS. rugosporus were grown on NZ Amine A medium [ATCC 172] at
30°C. E. coli was grown at 37°C in LB [16], supplemented with 100g ml−1 apramycin, 15 g ml−1 tetracycline, or 100 g ml−1 ampicil-
in. P. fluorescens strains were grown at 30°C on modified LB sup-
lemented with 50 g ml−1 kanamycin and 30 g ml−1 tetracycline,
f necessary, for 2 days. Vectors pOJ446 [17], pEFBA [18], and
HZ1358 [19] were described previously, and pBluescript II SK (+)
as from a commercial source [Stratagene]. pCIBhis was con-
tructed through cloning of a 270 bp PCR-fragment from the
-terminal expression region of pRSETB [Stratagene] including the
olyhistidine tag and the MCS into the BamHI site of pPEH14 [4].
NA Manipulation and Sequencing
lasmid DNA preparations, restriction endonuclease digestions, al-
aline phosphatase treatments, ligations, and other DNA manipula-
ions were performed according to standard procedures for E. coli
16]. A genomic library of S. rugosporus was constructed in pOJ446
ccording to published procedures [16] and packaged with Giga-
ack III XL extract from Stratagene. Total DNA of S. rugosporus
as isolated after treatment of the cells at 37°C for 1 hr with 10 mg
l−1 lysozyme in lysozyme buffer (10 mM Tris and 0.3 M saccha-
ose [pH 8]). The cells were pelleted and resuspended in NAE buffer
0.15 M NaCl and 0.1 M EDTA [pH 8]). Proteinase K solution and
DS were added to a final concentration of 0.2 mg ml−1 and 2%,
espectively. The cells were incubated at 37°C for a further 3 hr
nd at 60°C for an additional 30 min. DNA was purified by phenol/
hloroform extraction and ethanol precipitation. Southern analysis,
igoxigenin labeling of probes, hybridization, and detection were
erformed according to manufacturer’s recommendations (Roche).
ntroduction of DNA into S. rugosporus was performed through
. coli-Streptomyces conjugation routinely used for Streptomyces
20]. DNA sequencing was performed by MWG biotech Ebersberg.
omputer assisted database searches were carried out using the
USAR program package (EMBL Heidelberg) and the BLAST pro-
ram [21].
CR Amplification
egenerated oligonucleotides were designed to locate the halo-
enase gene in total DNA of S. rugosporus. They were derived from
our conserved motifs present in the amino acid sequences of
nown tryptophan halogenase proteins (Figure 2). These oligonu-
leotides were used to attempt PCR amplification using total DNA
rom S. rugosporus as the template. The sequences of two sense
ligonucleotides were SZ002 (motif II) 5#-TCGGYGTSGGCGARGC
ACCRTCCC-3# and SZ003 (motif I) 5#-TSGGCGGCGGCACYGC
GGMTGGATG-3# and those of the two antisense oligonucleotides
Z004 (motif IV) 5#-AGCATSGGRATCTTCCAGGTCCABCC-3# and
Z005 (motif III) 5#-GCCGGAGCAGTCGAYGAASAGGTC-3#. PCR
ixtures contained 50 ng of template DNA, 50 pmol of each primer,
mM MgCl2, 2.5 U Taq DNA Polymerase (MBI fermentas), 5%
MSO, and 0.2 mM dNTP-mix. Amplification was obtained by stan-
ard procedure with an annealing temperature of 63.5°C. The PCR
roduct of the oligonucleotides SZ003 and SZ005 was named
CR-hal and subsequently used as the DNA probe for Southern hy-
ridization.
onstruction of Plasmids
rom cosmid 6D1, a 4300 kb BamHI fragment was subcloned into
he BamHI site of pBluescript II SK (+) yielding pB1G that contained
he entire halogenase gene. For disruption of the halogenase gene,
he apramycin resistance gene from pEFBA was cloned blunt-
nded as a 1.5 kb HindIII-NdeI fragment into the blunt-ended PaeI
ite internal in the halogenase gene of pB1G leading to the plasmid
SZ594. The 5.8 kb BamHI fragment from pSZ594 was cloned into
he same site of pHZ1358 yielding pSZ614 (Figure 5A). Plasmid
SZ614 was used for disruption of the chromosomal pyrH gene in
. rugosporus (Figure 5B).
ene Expression
or the expression of pyrH in P. fluorescens, the gene was ampli-
ied by PCR. The following primers were used (restriction sites for
amHI and HindIII, respectively, are underlined and were included
o facilitate ligation into pCIBhis): 5#-ATCGGGATCCCCATATGA
CCGATCTGTGGTGATCGTGGGTG-3# for the 5# end of the halo-genase gene and 5#-ATGAAAGCTTTCATTGGATGCTGGCGAGGT
ACTCGTAGCAGC-3# for the 3# end of the gene. PCR reaction con-
Tryptophan 5-Halogenase
451ditions were as follows: 100 ng of template DNA were mixed with
50 pmol of each primer, 1 mM MgSO4, and 2 U Pfu DNA polymerase
in a total volume of 50 l containing 2 mM of each dNTP and 10%
DMSO. The reaction was performed under standard conditions
with an annealing temperature of 68.1°C. The PCR product was
purified, digested with BamHI and HindIII, and ligated into the same
sites of pCIBhis, generating pSZexM2. The amplified DNA se-
quence was verified by sequencing. The plasmid pSZexM2 was
then introduced into P. fluorescens BL915 ORF1 by conjugation,
as described earlier [22]. The halogenase gene was constitutively
expressed in P. fluorescens under control of the tac promoter [4].
Preparation of Crude Extracts, Protein Electrophoresis,
and Protein Measurements
Cells from a 2-day-old culture of P. fluorescens BL915 ORF1
pSZexM2 and control strain (containing pCIBhis) were harvested
by centrifugation and washed twice with saline. The cells were re-
suspended in 100 mM potassium phosphate buffer (pH 7.2) and
disrupted by sonication for 6 min (Branson sonifier 450, 160 W,
60% amplitude, 4°C). The crude extract was obtained by centrifu-
gation (two times at 22,100 g, 4°C, 30 min) and immediately dia-
lyzed against 10 mM potassium phosphate buffer (pH 7.2). Flavin
reductase-containing extracts were prepared from E. coli JM109
(DE3) pEE1001 [14]. Cells from an overnight culture were harvested
by centrifugation and washed once with 10 mM potassium phos-
phate buffer (pH 7.2). The cells were resuspended in 100 mM po-
tassium phosphate buffer (pH 7.2) and disrupted by sonication for
2.5 min. The cell debris was removed by centrifugation and the
crude extract containing Fre was used for enzyme assays after di-
alysis against 10 mM potassium phosphate buffer (pH 7.2) con-
taining 10% glycerol. SDS-PAGE was performed according to
Schägger and von Jagow [23] using 4.5% stacking gels and 10%
resolving gels. For the estimation of protein size, Mark12 MW stan-
dard (Novex) was used. Gels were stained for proteins with Coo-
massie Brillant Blue R250. Protein concentrations were determined
using the method of Whitaker and Granum [24].
Enzyme Assay
Halogenating activity was determined after incubating 100 l of
crude extract from P. fluorescens BL915 ORF1 pSZexM2 contain-
ing recombinant tryptophan 5-halogenase or 100 l of purified
PyrH, respectively, with 4.5 mU Fre [25], 10 M FAD, 2.4 mM NADH,
25 mM NaCl or NaBr, respectively, 0.6 mM L-tryptophan, and 10
mM potassium phosphate buffer (pH 7.2) in a total volume of 200
l at 30°C for 6 hr (crude extract) and for 90 min (purified PyrH),
respectively. The reaction was stopped by boiling in a water bath
for 5 min. After removal of precipitated protein by centrifugation,
20 l of the assay mixture was analyzed by HPLC. HPLC was per-
formed on a Nucleosil 100 RP-18 column (5m, 125 mm × 4.6 mm,
Bischoff) with MeOH/H2O/trifluoracetic acid (40:60:0.1) as the
eluent with a flow rate of 1 ml min−1 and UV detection at 220 nm
The products were identified by comparison of their retention times
with reference substances, HPLC-UV spectra, and HPLC-ESI-MS.
Purification of PyrH
All purification steps were performed at 4°C. For purification, the
cell-free extract was dialyzed overnight against 10 mM potassium
phosphate buffer (pH 7.2), and loaded onto a nickel-chelating
sepharose fast flow column (44 ml column volume). The column
was washed with buffer A (10 mM potassium phosphate buffer [pH
7.2] and 0.15 M NaCl) until the absorbance at 280 nm remained
constant. After a further washing step with 180 ml of 40% buffer B
(10 mM potassium phosphate buffer [pH 7.2], 150 mM NaCl, and
250 mM imidazole), PyrH was eluted with 100% buffer B. Fractions
(2 ml) containing PyrH, as judged by SDS-PAGE, were pooled and
dialyzed overnight against 10 mM potassium phosphate buffer (pH
7.2) containing 10% glycerol. The purified enzyme was stored
at −20°C.
1H NMR Analysis of 5-Chlorotryptophan
A large-scale reaction (6 × 3 ml) containing 10 mM potassium phos-
phate buffer [pH 7.2], 5 M FAD, 25 mM NaCl, 0.6 mM L-trypto-
phan, 1,560 U catalase, 5 mM NADH, 169 mU flavin reductase (Fre),
and 1.5 ml of cell-free crude extract was incubated at 30°C for 30min with shaking (150 rpm). The assay mixtures were heated to
95°C for 5 min and protein was removed by centrifugation. The
supernatant was fractionated by preparative HPLC using a Eu-
rosphere-100 RP-18 column (5 m, 250 mm × 20 mm, Knauer) with
MeOH/H2O/ammonium acetate (40:60:0.1) as the eluent at a flow
rate of 5 ml min−1. Fractions containing the chlorinated tryptophan
derivative were pooled and methanol was evaporated in vacuo. The
resulting aqueous solution was freeze dried. The remaining solid
was dissolved in D2O and analyzed by 1H NMR. 1H NMR spectros-
copy was performed in a Bruker NMR spectrometer DRX-500 sys-
tem (TMS d = 0). Authentic 5-chlorotryptophan was purchased from
Apin Chemicals Ltd.
Isolation of Pyrroindomycins
Spores of strains S. rugosporus NRRL 21084 and S. rugosporus
SZTF1Hal were inoculated in NZ Amine A medium and cultivated
at 30°C and 170 rpm for 3 days. Each seed culture was used to
inoculate (2.5%, v/v) four Erlenmeyer flasks containing 250 ml of
SO7 medium [3]. After incubation for 8 days under the same condi-
tions, cells were harvested by centrifugation. Since the pyrroindo-
mycins were found to be predominantly associated with the cell
pellet, the cells were resuspended in a small volume of water and
were twice extracted by shaking for 2 hr with 1.5 volumes of ethyl
acetate. The organic phase was carefully removed and evaporated
in vacuo. The dried extracts from the pellets of each strain were
redissolved in 100 l methanol and applied to HPLC analysis.
HPLC and HPLC-ESI-MS Analysis
Detection of tryptophan derivatives and pyrroindomycins was per-
formed by HPLC (Knauer, Berlin, Germany) on a reversed phase
column (Lichrosphere 100 RP-18, 5.0 m 250 × 4.6 mm, Bischoff),
with acetonitrile and 0.1% trifluoroacetic acid (TFA) in water as
eluent. A gradient from 10% to 100% acetonitrile over 20 min at a
flow rate of 1 ml min−1 was used. From each strain 20 l of the
extracts were injected. Detection and spectral characterization of
peaks were performed with a photodiode array detector. Pyrroin-
domycins were detected due to their characteristic UV/Vis spectra.
The halogenation status of the compounds was monitored by
HPLC-ESI-MS. For this purpose, cell-free extracts of the trypto-
phan halogenation assay or crude methanol extracts of pyrroindo-
mycins from cell extracts of wild-type and mutant strains were ana-
lyzed by HPLC-ESI-MS. Separations were performed on a Merck
Purospher column (RP-C18e, 125 × 4 mm, 4.0 m) with a flow rate
of 1.5 ml/min. The UV detector (λ = 214 nm) was connected in
series with the mass spectrometer. Solvent A was 0.1% TFA and
solvent B was acetonitrile/0.1%TFA (gradient 10%–100% over 10
min). Injection volumes were 20 l. HPLC-ESI-MS analysis was per-
formed on an Agilent 1100 HPLC system (Agilent, Waldbronn, Ger-
many) coupled to a Bruker Esquire 3000plus (Bruker-Daltonics,
Bremen, Germany) equipped with an ion-trap analyzer.
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